CDK9/cyc T2:0.626 nM (IC50)
CDK9/CycT1:1.68 nM (IC50)
CDK6/cycD1:2.92 nM (IC50)
CDK4/Cyc D1:3.96 nM (IC50)
CDK1/cycB:5.4 nM (IC50)
CDK1/cyc A:9.1 nM (IC50)
[1]. Dey J, et al. Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition. Sci Rep. 2017 Dec 21;7(1):18007.
陕西缔都医药有限责任公司
联系商家时请提及chemicalbook,有助于交易顺利完成!